Galaxy Surfactants Ltd. (IN:GALAXYSURF)
:GALAXYSURF
Top Page
Galaxy Surfactants Ltd.
(GALAXYSURF)
Select Model
Select Model
Rating:60Neutral
Price Target:
₹1,874.00
▼(-4.42% Downside)
Action:ReiteratedDate:12/02/25
Galaxy Surfactants Ltd. has a strong financial foundation, which is a significant positive factor. However, the technical analysis indicates bearish momentum, which is a major concern. The valuation is moderate, offering a balanced view. The absence of earnings call data and corporate events limits additional insights.
Positive Factors
Revenue Growth
Sustained revenue expansion (~26.7%) signals durable demand for Galaxy's surfactants across home and personal care segments. Over 2-6 months this underpins scale advantages, better fixed-cost absorption and supports reinvestment in higher-margin specialty grades and geographic expansion.
Negative Factors
Earnings Per Share Volatility
Negative EPS growth despite revenue gains signals profit-per-share pressure from margin swings, non-recurring items or capital changes. Over several months this can constrain dividend capacity and investor confidence, and may reflect operational or structural profitability risks to monitor.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained revenue expansion (~26.7%) signals durable demand for Galaxy's surfactants across home and personal care segments. Over 2-6 months this underpins scale advantages, better fixed-cost absorption and supports reinvestment in higher-margin specialty grades and geographic expansion.
Read all positive factors
Galaxy Surfactants Ltd. (GALAXYSURF) vs. iShares MSCI India ETF (INDA)
Market Cap
₹64.64B
Dividend Yield1.07%
Average Volume (3M)465.00
Price to Earnings (P/E)30.8
Beta (1Y)0.91
Revenue Growth22.63%
EPS Growth-8.57%
CountryIN
Employees1,762
SectorConsumer Defensive
Sector Strength42
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)16.60
Shares Outstanding35,454,754
10 Day Avg. Volume455
30 Day Avg. Volume465
Financial Highlights & Ratios
PEG Ratio21.32
Price to Book (P/B)3.14
Price to Sales (P/S)1.76
P/FCF Ratio31.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,647.00Price Target Upside35.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)94.39
Revenue Forecast (FY)₹54.85B
Galaxy Surfactants Ltd. Business Overview & Revenue Model
Company Description
Galaxy Surfactants Limited manufactures and markets specialty chemicals for personal and home care industries in India and internationally. The company offers fatty alcohol surfactants, fatty alcohol ethoxylates, alkyl benzene sulphonic acids, foa...
How the Company Makes Money
Galaxy Surfactants primarily makes money by manufacturing and selling specialty chemical ingredients—mainly surfactants and related performance ingredients—used by home and personal care companies and other formulators. Revenue is generated from (...
Galaxy Surfactants Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.91B | 42.24B | 37.65B | 44.45B | 36.53B | 27.45B |
| Gross Profit | 13.21B | 13.38B | 11.58B | 13.16B | 10.44B | 9.55B |
| EBITDA | 4.87B | 4.84B | 4.98B | 5.75B | 4.11B | 4.58B |
| Net Income | 2.86B | 3.05B | 3.01B | 3.81B | 2.63B | 3.02B |
Balance Sheet | ||||||
| Total Assets | 37.78B | 34.62B | 29.15B | 27.34B | 26.01B | 20.49B |
| Cash, Cash Equivalents and Short-Term Investments | 6.55B | 5.00B | 4.38B | 2.47B | 692.40M | 1.54B |
| Total Debt | 2.68B | 2.10B | 1.87B | 3.27B | 4.21B | 2.89B |
| Total Liabilities | 12.43B | 11.00B | 7.35B | 8.52B | 10.26B | 7.48B |
| Stockholders Equity | 25.35B | 23.63B | 21.79B | 18.83B | 15.74B | 13.01B |
Cash Flow | ||||||
| Free Cash Flow | 993.10M | 2.37B | 3.60B | 4.27B | -1.50B | 2.58B |
| Operating Cash Flow | 1.69B | 4.21B | 5.18B | 5.73B | 49.30M | 3.65B |
| Investing Cash Flow | -1.11B | -2.95B | -3.44B | -1.49B | -841.20M | -1.65B |
| Financing Cash Flow | 53.10M | -1.57B | -1.89B | -2.64B | 591.50M | -1.65B |
Galaxy Surfactants Ltd. Technical Analysis
Positive
1960.70
Price Trends
1817.34
Positive
1912.67
Negative
2148.53
Negative
Market Momentum
-24.19
Negative
57.32
Neutral
96.49
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GALAXYSURF, the sentiment is Positive. The current price of 1960.7 is above the 20-day moving average (MA) of 1695.13, above the 50-day MA of 1817.34, and below the 200-day MA of 2148.53, indicating a neutral trend. The MACD of -24.19 indicates Negative momentum. The RSI at 57.32 is Neutral, neither overbought nor oversold. The STOCH value of 96.49 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:GALAXYSURF.
Galaxy Surfactants Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹82.06B | 30.50 | ― | 3.28% | 3.01% | 22.98% | |
66 Neutral | ₹155.53B | -90.62 | ― | 0.28% | 14.55% | -20.61% | |
64 Neutral | ₹82.79B | 31.99 | ― | 1.24% | 1.62% | -7.32% | |
64 Neutral | ₹76.52B | 27.59 | ― | 0.04% | 89.51% | 188.01% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ₹64.64B | 30.80 | ― | 1.07% | 22.63% | -8.57% | |
54 Neutral | ₹112.17B | 46.47 | ― | ― | 10.59% | 67.55% |
* Consumer Defensive Sector Average
IN:GALAXYSURF
Galaxy Surfactants Ltd.
1,823.20
-346.58
-15.97%
IN:HONASA
Honasa Consumer Limited
344.75
115.85
50.61%
IN:JYOTHYLAB
Jyothy Labs Limited
225.45
-142.49
-38.73%
IN:MANORAMA
Manorama Industries Ltd.
1,281.55
255.14
24.86%
IN:PGHL
Procter & Gamble Health Ltd.
4,943.65
-239.79
-4.63%
IN:ZYDUSWELL
Zydus Wellness Limited
488.85
140.54
40.35%
Galaxy Surfactants Ltd. Corporate Events
Galaxy Surfactants Schedules Investor Conference Meetings for February 25
Feb 20, 2026
Galaxy Surfactants Ltd. has announced that its officials will participate in an investor conference organized by IIFL Capital on February 25, 2026, in Mumbai, with the meetings scheduled to take place in person during the afternoon. The company st...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.